Pharmaceuticals s a clinical-stage biopharmaceutical company focused on developing a novel class of drugs called helicon peptides. These stabilized, cell-penetrant alpha-helical peptides are designed using artificial intelligence and machine learning to target historically "undruggable" intracellular proteins, particularly flat protein-protein interaction surfaces
Sponsorship in October 2026
There is no data, please login to become a sponsor.
